Glucose B.Braun (Glucose Monohydrate)

Glucose B.Braun is indicated for several clinical situations where intravenous carbohydrate delivery is required.

• Parenteral nutrition in patients unable to receive enteral feeding.
• Treatment of hypoglycemia when oral glucose is not feasible.
• Fluid and electrolyte replacement as part of balanced IV therapy.
• Intra‑operative glucose support during surgery.
• Management of metabolic demands in critically ill patients.

Intravenous administration of glucose monohydrate may be associated with both common and serious adverse reactions.

Common

• Transient hyperglycemia.
• Local irritation or phlebitis at the infusion site.
• Electrolyte shifts, particularly mild hypokalemia.
• Fluid overload in patients receiving large volumes.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic or anaphylactic reaction to the solution.
• Significant volume overload causing pulmonary edema.
• Marked electrolyte disturbances such as severe hypokalemia or hypernatremia.

Clinicians should observe several precautions when prescribing or administering Glucose B.Braun to ensure patient safety.

• Verify blood glucose levels before and during infusion.
• Assess fluid balance and avoid excessive volume in patients with cardiac or renal impairment.
• Monitor serum electrolytes, especially potassium and sodium, during prolonged therapy.
• Use caution in patients with known hypersensitivity to glucose solutions.
• Consider pregnancy status; safety data are limited.
• Ensure compatibility with other IV medications before mixing.

Glucose B.Braun can interact with other agents administered intravenously; some combinations should be avoided while others require careful monitoring.

Avoid

• Co‑administration with other hypertonic dextrose solutions that may cause severe hyperglycemia.
• Simultaneous infusion of insulin in excess of the glucose load without appropriate monitoring.

Use with caution

• Diuretics that may exacerbate electrolyte shifts.
• Corticosteroids, which can increase glucose levels.
• Beta‑adrenergic agonists that may raise blood glucose.
• Other IV fluids containing electrolytes that could alter serum balance.
• Medications affecting potassium, such as potassium‑sparing diuretics.